Patents by Inventor Scott Edward Osborne
Scott Edward Osborne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8309788Abstract: The invention provides an absorbent article, at least a portion of which has a protease inhibitor incorporated therein to decrease the activity of proteases that may otherwise initiate or contribute to inflammation of the skin of a wearer of the article resulting in skin irritation or dermatitis. The article can further comprise a delivery system for releasably containing and delivering the protease inhibitor to at least a portion of the skin of the wearer. The delivery system can comprise a skin care composition and at least a portion of the composition, including the protease inhibitor, is automatically transferred from the article to the wearer's skin without manual intervention during normal usage of the article to form a defense against protease activity.Type: GrantFiled: January 23, 2009Date of Patent: November 13, 2012Assignee: The Procter and Gamble CompanyInventors: Francis James Rourke, Scott Edward Osborne, Donald Carroll Roe, Todd Laurence Underiner, John McMillan McIver, Timothy Bates
-
Patent number: 7771925Abstract: A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.Type: GrantFiled: April 25, 2007Date of Patent: August 10, 2010Assignee: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin
-
Patent number: 7771924Abstract: A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.Type: GrantFiled: April 25, 2007Date of Patent: August 10, 2010Assignee: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin
-
Patent number: 7767389Abstract: A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.Type: GrantFiled: April 25, 2007Date of Patent: August 3, 2010Assignee: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin
-
Patent number: 7763419Abstract: A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.Type: GrantFiled: April 25, 2007Date of Patent: July 27, 2010Assignee: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin
-
Publication number: 20090131890Abstract: The invention provides an absorbent article, at least a portion of which has a protease inhibitor incorporated therein to decrease the activity of proteases that may otherwise initiate or contribute to inflammation of the skin of a wearer of the article resulting in skin irritation or dermatitis. The article can further comprise a delivery system for releasably containing and delivering the protease inhibitor to at least a portion of the skin of the wearer. The delivery system can comprise a skin care composition and at least a portion of the composition, including the protease inhibitor, is automatically transferred from the article to the wearer's skin without manual intervention during normal usage of the article to form a defense against protease activity.Type: ApplicationFiled: January 23, 2009Publication date: May 21, 2009Inventors: Francis James Rourke, Scott Edward Osborne, Donald Carroll Roe, Todd Laurence Underiner, John McMillan Mciver, Timothy Bates
-
Patent number: 7229778Abstract: A method for determining the relative benefits of products which affect animal epithelial tissue is provided. Also provided is a method for evaluating quantitative changes on one or more affected surfaces of epithelial tissue of a subject caused by a test product.Type: GrantFiled: February 26, 2004Date of Patent: June 12, 2007Assignee: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Susan Baldwin
-
Publication number: 20040175343Abstract: The present invention relates to a novel composition for efficiently releasing hydrophilic or water-soluble skin care actives from an oleaginous composition. The substantially oleaginous composition of the present invention comprises: (1) at least one skin care active; (2) a release agent having an HLB of at least about 3; and (3) a hydrophobic barrier protectant. The novel release composition may be topically applied to skin using a dispensing means such as an absorbent article, a wipe, a bandage, a pad, a canister, a stick, an aerosol dispenser, a sprayer, and the like.Type: ApplicationFiled: March 19, 2004Publication date: September 9, 2004Applicant: The Procter & Gamble CompanyInventors: Scott Edward Osborne, George Endel Deckner, Thomas James Klofta, Victor Nicholas Vega
-
Patent number: 6756032Abstract: The present invention relates to a method comprising subjecting a test site of a responsive system to a primary challenge; subjecting the same test site to a secondary challenge, wherein the secondary challenge is designed to enhance and/or prolong a response of the responsive system to the primary challenge, without confounding the response nor altering the mechanism by which the primary challenge elicits a response from the responsive system; and assessing the response subsequent to the secondary challenge. The methods claimed herein also preferably comprise the additional step(s) of subjecting test site(s) to one or more pre-challenge intervention(s) and/or post-challenge intervention(s) and/or concurrent-challenge intervention(s).Type: GrantFiled: July 12, 2000Date of Patent: June 29, 2004Assignee: The Procter & Gamble CompanyInventors: Bruce Ernest Tepper, Susan Baldwin, Scott Edward Osborne, Mauricio Odio
-
Patent number: 6723788Abstract: The present invention relates to compositions which comprise one or more polymer conjugates having the formula: wherein T is a heterocyclic unit which is capable of inhibiting one or more proteolytic enzymes; L is a linking group; [Poly] is a polymeric unit, i indicates the number of said heterocyclic units which comprise said conjugate and has the value of from 1 to 100; z is 0 or 1, said polymer conjugates suitable for use in preventing skin irritation resulting from exposure of the skin to body fluids, inter alia, feces, menstrual fluid. The conjugates of the present invention are useful in diapers, dressings, sanitary napkins, and the like.Type: GrantFiled: September 8, 2000Date of Patent: April 20, 2004Assignee: The Procter & Gamble CompanyInventors: Scott Edward Osborne, Todd Laurence Underiner
-
Patent number: 6716441Abstract: The present invention relates to a novel composition for efficiently releasing hydrophilic or water-soluble skin care actives from an oleaginous composition. The substantially oleaginous composition of the present invention comprises: (1) at least one skin care active; (2) a release agent having an HLB of at least about 3; and (3) a hydrophobic barrier protectant. The novel release composition may be topically applied to skin using a dispensing means such as an absorbent article, a wipe, a bandage, a pad, a canister, a stick, an aerosol dispenser, a sprayer, and the like.Type: GrantFiled: December 17, 1999Date of Patent: April 6, 2004Assignee: The Procter & Gamble CompanyInventors: Scott Edward Osborne, George Endel Deckner, Thomas James Klofta, Victor Nicholas Vega
-
Patent number: 6703536Abstract: An absorbent article, at least a portion of which comprises a skin care composition that comprises an enzyme inhibitor and is at least partially transferred from the article to the skin of a wearer of the article as a result of normal contact, wearer motion and/or body heat. The enzyme inhibitor is transferred to the skin with the skin care composition and is available at the skin/urine and skin/feces interfaces to inhibit enzymatic activity on the skin and to reduce or prevent the occurrence of inflammation. Repeated application of similar treated articles to the wearer's skin provides an available source with which the enzyme inhibitor transfers onto the skin continuously over time and accumulates to provide a proactive defense against harmful enzymes for the treatment and/or prevention of diaper dermatitis.Type: GrantFiled: December 18, 2002Date of Patent: March 9, 2004Assignee: The Procter & Gamble CompanyInventors: Donald Carroll Roe, Francis James Rourke, Scott Edward Osborne
-
Publication number: 20030139711Abstract: An absorbent article, at least a portion of which comprises a skin care composition that comprises an enzyme inhibitor and is at least partially transferred from the article to the skin of a wearer of the article as a result of normal contact, wearer motion and/or body heat. The enzyme inhibitor is transferred to the skin with the skin care composition and is available at the skin/urine and skin/feces interfaces to inhibit enzymatic activity on the skin and to reduce or prevent the occurrence of inflammation. Repeated application of similar treated articles to the wearer's skin provides an available source with which the enzyme inhibitor transfers onto the skin continuously over time and accumulates to provide a proactive defense against harmful enzymes for the treatment and/or prevention of diaper dermatitis.Type: ApplicationFiled: December 18, 2002Publication date: July 24, 2003Applicant: The Procter & Gamble CompanyInventors: Donald Carroll Roe, Francis James Rourke, Scott Edward Osborne
-
Patent number: 6541629Abstract: The present invention relates to polymer conjugates having the formula: wherein T is a heterocyclic unit which is capable of inhibiting one or more proteolytic enzymes; L is a linking group; [Poly] is a polymeric unit, i indicates the number of said heterocyclic units which comprise said conjugate and has the value of from 1 to 100; z is 0 or 1, said polymer conjugates suitable for use in preventing skin irritation resulting from exposure of the skin to body fluids, inter alia, feces, menstrual fluid. The conjugates of the present invention are useful in diapers, dressings, sanitary napkins, and the like.Type: GrantFiled: September 8, 2000Date of Patent: April 1, 2003Assignee: The Procter & Gamble CompanyInventors: Scott Edward Osborne, Todd Laurence Underiner
-
Publication number: 20020192407Abstract: A premoistened wipe comprising:Type: ApplicationFiled: February 26, 2002Publication date: December 19, 2002Applicant: The Procter & Gamble CompanyInventors: Stephen Worth Hendrix, Scott Edward Osborne, Marc Fredric Richards, Susie Richards, Bonnie Kay West
-
Patent number: 6207596Abstract: A disposable wipe which comprises a substrate, an antimicrobial protease inhibitor, and a liquid. The antimicrobial protease inhibitor may be added directly to the substrate and/or added directly to the liquid. The antimicrobial protease inhibitor is capable of inhibiting deleterious fecal microorganisms and protease enzymes thereby aiding in the prevention of diaper dermatitis. The wipe may optionally include other ingredients examples of which include humectants, emollients, surfactants, fragrances, emulsifiers, and preservatives.Type: GrantFiled: November 9, 1998Date of Patent: March 27, 2001Assignee: The Procter & Gamble CompanyInventors: Francis James Rourke, Marc Frederic Richards, Scott Edward Osborne